Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Telesis Bio Inc (TBIO)

Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,294
  • Shares Outstanding, K 1,683
  • Annual Sales, $ 27,510 K
  • Annual Income, $ -47,720 K
  • 60-Month Beta 1.74
  • Price/Sales 0.22
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade TBIO with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 165.90%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,338.27% on 02/15/24
  • IV Low 0.00% on 07/02/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 30
  • Open Int (30-Day) 30

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -5.04
  • Growth Rate Est. (year over year) +19,921.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.03 +24.96%
on 06/11/24
5.40 -30.00%
on 06/17/24
-0.24 (-5.97%)
since 06/03/24
3-Month
3.03 +24.96%
on 06/11/24
8.44 -55.22%
on 04/04/24
-4.81 (-55.97%)
since 04/03/24
52-Week
3.03 +24.96%
on 06/11/24
31.50 -88.00%
on 07/12/23
-24.30 (-86.54%)
since 07/03/23

Most Recent Stories

More News
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines...

TBIO : 3.78 (+1.07%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGRF, SIC, SAFM, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / August 26, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: TGR Financial, Inc. (OTCQX:TGRF) concerning potential...

TGRF : 15.5500 (+1.83%)
SIC : 14.49 (+0.07%)
SAFM : 204.00 (-2.51%)
TBIO : 3.78 (+1.07%)
INVESTIGATION: Halper Sadeh LLP Investigates CMO, TBIO, SIC, SAFM; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CMO : 6.50 (+2.52%)
TBIO : 3.78 (+1.07%)
SIC : 14.49 (+0.07%)
SAFM : 204.00 (-2.51%)
INVESTIGATION: Halper Sadeh LLP Investigates SAFM, SBKK, SQ, TBIO; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
SBKK : 18.5800 (+1.03%)
SQ : 64.44 (-0.22%)
TBIO : 3.78 (+1.07%)
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update

-- Entered into a definitive agreement under which Sanofi will acquire, subject to customary  conditions to closing, all outstanding shares of Translate Bio with a goal of advancing deployment of mRNA...

TBIO : 3.78 (+1.07%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates SQ, TBIO, OSBC, IKNX; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SQ : 64.44 (-0.22%)
TBIO : 3.78 (+1.07%)
OSBC : 14.80 (-2.63%)
IKNX : 33.90 (-0.29%)
Lifshitz Law Firm, P.C. Announces Investigation of HFC, OSBC, RYFL and TBIO

NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) --

HFC : 36.39 (+1.99%)
OSBC : 14.80 (-2.63%)
RYFL : 20.2500 (-1.22%)
TBIO : 3.78 (+1.07%)
TRANSLATE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Translate Bio - TBIO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Translate Bio (NasdaqGS: TBIO) to Sanofi (NasdaqGS:...

TBIO : 3.78 (+1.07%)
SNY : 48.86 (+0.66%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Translate Bio, Inc. Merger

WILMINGTON, Del., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Translate Bio, Inc. (“Translate Bio”) (NASDAQ GS: TBIO ) regarding possible breaches...

TBIO : 3.78 (+1.07%)
TRANSLATE BIO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of TBIO and Encourages Investors to Contact the Firm

NEW YORK, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Translate...

TBIO : 3.78 (+1.07%)
SNY : 48.86 (+0.66%)

Business Summary

Telesis Bio is an automated multi-omic and synthetic biology solutions company. Its BioXp(R) system consolidates, automates and optimizes the entire synthesis, cloning and amplification workflow. Telesis Bio, formerly known as Codex DNA Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 4.05
2nd Resistance Point 3.91
1st Resistance Point 3.85
Last Price 3.78
1st Support Level 3.65
2nd Support Level 3.51
3rd Support Level 3.45

See More

52-Week High 31.50
Fibonacci 61.8% 20.62
Fibonacci 50% 17.26
Fibonacci 38.2% 13.90
Last Price 3.78
52-Week Low 3.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar